These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21446902)

  • 1. Effect of simvastatin use on autonomic function in patients with end stage renal disease.
    Narsipur SS; Srinivasan B; Singh B
    Cardiovasc Hematol Disord Drug Targets; 2011 Mar; 11(1):53-7. PubMed ID: 21446902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The VITAH trial VITamin D supplementation and cardiac Autonomic tone in Hemodialysis: a blinded, randomized controlled trial.
    Mann MC; Exner DV; Hemmelgarn BR; Hanley DA; Turin TC; MacRae JM; Ahmed SB
    BMC Nephrol; 2014 Aug; 15():129. PubMed ID: 25098377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of angiotensin converting enzyme inhibitor treatment on cardiac autonomic modulation in patients receiving haemodialysis.
    Ondocin PT; Narsipur SS
    Nephrology (Carlton); 2006 Dec; 11(6):497-501. PubMed ID: 17199786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between autonomic nervous dysfunction and cellular inflammation in end-stage renal disease.
    Seibert E; Zohles K; Ulrich C; Kluttig A; Nuding S; Kors JA; Swenne CA; Werdan K; Fiedler R; Girndt M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):210. PubMed ID: 27809785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.
    Panichi V; Paoletti S; Mantuano E; Manca-Rizza G; Filippi C; Santi S; Taccola D; Donadio C; Tramonti G; Innocenti M; Casto G; Consani C; Sbragia G; Franzoni F; Galetta F; Panicucci E; Barsotti G
    Nephrol Dial Transplant; 2006 Feb; 21(2):337-44. PubMed ID: 16249194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relations of inflammatory markers to lipid levels and autonomic tone in patients with moderate and severe chronic kidney disease and in patients under maintenance hemodialysis.
    Psychari SN; Sinos L; Iatrou C; Liakos G; Apostolou TS
    Clin Nephrol; 2005 Dec; 64(6):419-27. PubMed ID: 16370154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women.
    Koh KK; Schenke WH; Waclawiw MA; Csako G; Cannon RO
    Circulation; 2002 Apr; 105(13):1531-3. PubMed ID: 11927515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin restores cardiac autonomic response to acute hypoxia in hypercholesterolaemia.
    Brasileiro-Santos MS; Barreto-Filho JA; Santos RD; Chacra AP; Sangaleti CT; Alvez G; Bezerra OC; Bortoloto LA; Irigoyen MC; Consolim-Colombo FM
    Eur J Clin Invest; 2013 Dec; 43(12):1291-8. PubMed ID: 24102438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
    Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C-reactive protein and in vivo oxidized LDL.
    van den Akker JM; Bredie SJ; Diepenveen SH; van Tits LJ; Stalenhoef AF; van Leusen R
    J Nephrol; 2003; 16(2):238-44. PubMed ID: 12768071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
    Lewin AJ; Kipnes MS; Meneghini LF; Plotkin DJ; Perevozskaya IT; Shah S; Maccubbin DL; Mitchel YB; Tobert JA;
    Clin Ther; 2004 Mar; 26(3):379-89. PubMed ID: 15110130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
    Saltissi D; Morgan C; Rigby RJ; Westhuyzen J
    Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective evaluation of the effect of simvastatin on heart rate variability in non-ischemic cardiomyopathy.
    Gentlesk PJ; Wiley T; Taylor AJ
    Am Heart J; 2005 Sep; 150(3):478-83. PubMed ID: 16169328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
    Robinson JG; Nedergaard BS; Rogers WJ; Fialkow J; Neutel JM; Ramstad D; Somaratne R; Legg JC; Nelson P; Scott R; Wasserman SM; Weiss R;
    JAMA; 2014 May; 311(18):1870-82. PubMed ID: 24825642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients.
    Bays HE; Stein EA; Shah AK; Maccubbin DL; Mitchel YB; Mercuri M
    Am J Cardiol; 2002 Nov; 90(9):942-6. PubMed ID: 12398959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic dysregulation in patients awaiting kidney transplantation.
    Hathaway DK; Cashion AK; Milstead EJ; Winsett RP; Cowan PA; Wicks MN; Gaber AO
    Am J Kidney Dis; 1998 Aug; 32(2):221-9. PubMed ID: 9708605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
    Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.